RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Volpara Health Technologies Stock

Volpara Health Technologies Revenue 2024

Volpara Health Technologies Revenue

37.53 M NZD

Ticker

VHT.AX

ISIN

NZVHTE0001S6

WKN

A2DVK1

In 2024, Volpara Health Technologies's sales reached 37.53 M NZD, a 7.18% difference from the 35.01 M NZD sales recorded in the previous year.

The Volpara Health Technologies Revenue history

YEARREVENUE (undefined NZD)GROSS MARGIN (%)
2027e58.255,61
2026e53.1560,90
2025e45.0571,85
2024e37.5386,25
202335.0192,45
202226.1191,23
202119.7591,43
202012.685,94
2019582,56
20182.8176,99
20172.0566,78
20162.6176,28
20152.4184,56
20141.4993,96

Volpara Health Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Volpara Health Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Volpara Health Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Volpara Health Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Volpara Health Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Volpara Health Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Volpara Health Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Volpara Health Technologies’s growth potential.

Volpara Health Technologies Revenue, EBIT and net profit per share

DateVolpara Health Technologies RevenueVolpara Health Technologies EBITVolpara Health Technologies Net Income
2027e58.2 M NZD17.87 M NZD2.31 M NZD
2026e53.15 M NZD-3.16 M NZD-1.03 M NZD
2025e45.05 M NZD-6.8 M NZD-3.6 M NZD
2024e37.53 M NZD-10.34 M NZD-7.84 M NZD
202335.01 M NZD-13.37 M NZD-9.8 M NZD
202226.11 M NZD-16.76 M NZD-16.44 M NZD
202119.75 M NZD-19.24 M NZD-17.49 M NZD
202012.6 M NZD-24.09 M NZD-20.37 M NZD
20195 M NZD-12.28 M NZD-11.74 M NZD
20182.81 M NZD-9.07 M NZD-8.82 M NZD
20172.05 M NZD-9.5 M NZD-9.57 M NZD
20162.61 M NZD-4.01 M NZD-30.36 M NZD
20152.41 M NZD-2.31 M NZD-3.02 M NZD
20141.49 M NZD-2.22 M NZD-2.78 M NZD

Volpara Health Technologies stock margins

The Volpara Health Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Volpara Health Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Volpara Health Technologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Volpara Health Technologies's sales revenue. A higher gross margin percentage indicates that the Volpara Health Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Volpara Health Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Volpara Health Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Volpara Health Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Volpara Health Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Volpara Health Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Volpara Health Technologies Margin History

Volpara Health Technologies Gross marginVolpara Health Technologies Profit marginVolpara Health Technologies EBIT marginVolpara Health Technologies Profit margin
2027e92.45 %30.7 %3.97 %
2026e92.45 %-5.94 %-1.93 %
2025e92.45 %-15.1 %-7.98 %
2024e92.45 %-27.55 %-20.88 %
202392.45 %-38.2 %-27.99 %
202291.23 %-64.19 %-62.96 %
202191.43 %-97.41 %-88.56 %
202085.94 %-191.18 %-161.65 %
201982.56 %-245.54 %-234.82 %
201876.99 %-322.4 %-313.58 %
201766.78 %-463.85 %-467.56 %
201676.28 %-153.48 %-1,161.4 %
201584.56 %-95.89 %-125.45 %
201493.96 %-148.99 %-186.58 %

Volpara Health Technologies Aktienanalyse

What does Volpara Health Technologies do?

Volpara Health Technologies Ltd is a medical technology company that specializes in offering products and services for breast cancer diagnosis and treatment. The company was founded in 2009 in New Zealand and has its headquarters in Wellington, as well as branches in the US, UK, and Australia. The business model of Volpara revolves around providing a cloud-based software platform called VolparaEnterprise, specifically developed for breast cancer diagnosis and treatment. This platform offers radiologists and radiological screening centers a complete range of tools to assess risks, make diagnoses, and plan treatments. It integrates automatic image analysis, artificial intelligence, and machine learning to enable more accurate and faster screenings. Volpara also assists in the interpretation of mammography images, particularly in assessing breast density, which is an important risk factor for the development of breast cancer. The company has developed a range of products, including VolparaDensity, VolparaLive! (formerly MRS), VolparaScore, and VolparaHealthchecks. Volpara has several divisions focusing on different aspects of breast cancer diagnosis and treatment: 1. VolparaClinical: This division is responsible for developing products for breast cancer diagnosis and assessment. These products include automated image analysis software and services for radiologists. 2. VolparaResearch: This division conducts clinical studies and research activities to expand knowledge and understanding of breast cancer. 3. VolparaEnterprise: This division offers a cloud-based software platform for radiological screening centers. The platform enables monitoring of image quality, risk assessment, disaster management, and continuing education for image screeners. 4. Volpara Solutions: This division is responsible for developing solutions for clinical decision support and patient management. The products offered by Volpara include VolparaDensity, an automated software for assessing women's breast density, VolparaLive!, an image analysis software for real-time monitoring of mammography image quality, VolparaScore, an automated software for assessing women's breast cancer risk, and VolparaHealthchecks, a set of tools for monitoring and treating breast cancer patients and assessing the risk for women with higher breast density. In conclusion, Volpara Health Technologies Ltd is a leading company in breast cancer diagnosis and treatment. The company aims to improve the efficiency and accuracy of mammography screenings and precise diagnosis of breast cancer. With a wide range of products and services, Volpara Health Technologies Ltd is on the right path to saving lives and winning the battle against breast cancer. Volpara Health Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Volpara Health Technologies's Sales Figures

The sales figures of Volpara Health Technologies originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Volpara Health Technologies’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Volpara Health Technologies's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Volpara Health Technologies’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Volpara Health Technologies stock

How much revenue did Volpara Health Technologies generate this year?

Volpara Health Technologies has achieved a revenue of 37.53 M NZD this year.

How much was the turnover of the company Volpara Health Technologies compared to the previous year?

The revenue of Volpara Health Technologies has increased by 7.18% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Volpara Health Technologies?

The revenue of Volpara Health Technologies is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Volpara Health Technologies measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Volpara Health Technologies so important for investors?

The revenue of Volpara Health Technologies is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Volpara Health Technologies pay?

Over the past 12 months, Volpara Health Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Volpara Health Technologies is expected to pay a dividend of 0 NZD.

What is the dividend yield of Volpara Health Technologies?

The current dividend yield of Volpara Health Technologies is .

When does Volpara Health Technologies pay dividends?

Volpara Health Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Volpara Health Technologies?

Volpara Health Technologies paid dividends every year for the past 0 years.

What is the dividend of Volpara Health Technologies?

For the upcoming 12 months, dividends amounting to 0 NZD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Volpara Health Technologies located?

Volpara Health Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Volpara Health Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Volpara Health Technologies from 9/30/2024 amounting to 0 NZD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Volpara Health Technologies pay the last dividend?

The last dividend was paid out on 9/30/2024.

What was the dividend of Volpara Health Technologies in the year 2023?

In the year 2023, Volpara Health Technologies distributed 0 NZD as dividends.

In which currency does Volpara Health Technologies pay out the dividend?

The dividends of Volpara Health Technologies are distributed in NZD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Volpara Health Technologies

Our stock analysis for Volpara Health Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Volpara Health Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.